The Fanconi anemia pathway and ubiquitin

BMC Biochemistry

Volumn 8, Issue SUPPL. 1, 2007, Pages

  Jacquemont, Céline ^a   Taniguchi, Toshiyasu ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BUTADIENE DIEPOXIDE; CISPLATIN; CURCUMIN; FANCONI ANEMIA GROUP D2 PROTEIN; MELPHALAN; MITOMYCIN C; PROTEIN FANCN; RAD51 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; FANCONI ANEMIA PROTEIN;

DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; FANCONI ANEMIA; HUMAN; NONHUMAN; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; ENZYMOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HUMANS; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 38449103060     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-8-S1-S10     Document Type: Review

References (137)

1. The emerging genetic and molecular basis of Fanconi anaemia. H Joenje KJ Patel, Nat Rev Genet 2001 2 6 446 457 10.1038/35076590 11389461
2. X-linked inheritance of Fanconi anemia complementation group B. AR Meetei M Levitus Y Xue AL Medhurst M Zwaan C Ling MA Rooimans P Bier M Hoatlin G Pals, Nat Genet 2004 36 11 1219 1224 10.1038/ng1458 15502827
3. Inherited bone marrow failure syndromes. BP Alter, Nathan and Oski's Hematology of Infancy and Childhood Philadelphia: PA Saunders, Nathan DG, Orkin SH, Ginsburg D, Look AT, Oski FA, 6 2003 1 280 365
4. Fanconi Anemia. AD Auerbach M Buchwald H Joenje, The Metabolic and Molecular Bases of Inherited Disease New York: McGraw-Hill, Scriver CR, Sly WS, Childs B, Beaudet AL, Valle D, Kinzler KW, Vogelstein B, 8th edn 2001 1 753 768
5. The Fanconi anaemia/BRCA pathway. AD D'Andrea M Grompe, Nat Rev Cancer 2003 3 1 23 34 10.1038/nrc970 12509764
6. Molecular pathogenesis of Fanconi anemia: recent progress. T Taniguchi AD D'Andrea, Blood 2006 107 11 4223 4233 10.1182/blood-2005-10-4240 16493006
7. The Fanconi Anemia/BRCA pathway: new faces in the crowd. RD Kennedy AD D'Andrea, Genes Dev 2005 19 24 2925 2940 10.1101/gad.1370505 16357213
8. The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair. KD Mirchandani AD D'Andrea, Exp Cell Res 2006 312 14 2647 2653 10.1016/j.yexcr. 2006.06.014 16859679
9. Dedicated to the core: understanding the Fanconi anemia complex. AM Gurtan AD D'Andrea, DNA Repair (Amst) 2006 5 9-10 1119 1125 10.1016/j.dnarep. 2006.05.009 16784902
10. Fanconi anaemia genes and susceptibility to cancer. CG Mathew, Oncogene 2006 25 43 5875 5884 10.1038/sj.onc.1209878 16998502
11. Tracing the network connecting BRCA and Fanconi anaemia proteins. AR Venkitaraman, Nat Rev Cancer 2004 4 4 266 276 10.1038/nrc1321 15057286
12. Fanconi anemia. GC Bagby BP Alter, Semin Hematol 2006 43 3 147 156 10.1053/j.seminhematol.2006.04.005 16822457
13. Fanconi Anemia (Cross)linked to DNA Repair. LJ Niedernhofer AS Lalai JH Hoeijmakers, Cell 2005 123 7 1191 1198 10.1016/j.cell.2005.12.009 16377561
14. Disruption of the Fanconi anemia/BRCA pathway in sporadic cancer. A Lyakhovich J Surralles, Cancer Lett 2006 232 1 99 106 10.1016/j.canlet.2005.07. 038 16246487
15. Molecular pathogenesis of Fanconi anemia. N Collins GM Kupfer, Int J Hematol 2005 82 3 176 183 10.1532/IJH97.05108 16207587
16. Fanconi anaemia and leukaemia - clinical and molecular aspects. M Tischkowitz I Dokal, Br J Haematol 2004 126 2 176 191 10.1111/j.1365-2141.2004. 05023.x 15238138
17. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). DI Kutler B Singh J Satagopan SD Batish M Berwick PF Giampietro H Hanenberg AD Auerbach, Blood 2003 101 4 1249 1256 10.1182/blood-2002-07-2170 12393516
18. Cancer incidence in persons with Fanconi anemia. PS Rosenberg MH Greene BP Alter, Blood 2003 101 3 822 826 10.1182/blood-2002-05-1498 12393424
19. Cancer in Fanconi anemia, 1927-2001. BP Alter, Cancer 2003 97 2 425 440 10.1002/cncr.11046 12518367
20. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. JE Wagner J Tolar O Levran T Scholl A Deffenbaugh J Satagopan L Ben-Porat K Mah SD Batish DI Kutler, Blood 2004 103 8 3226 3229 10.1182/blood-2003-09-3138 15070707
21. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. K Offit O Levran B Mullaney K Mah K Nafa SD Batish R Diotti H Schneider A Deffenbaugh T Scholl, J Natl Cancer Inst 2003 95 20 1548 1551 14559878
22. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. B Hirsch A Shimamura L Moreau S Baldinger M Hag-Alshiekh B Bostrom S Sencer AD D'Andrea, Blood 2004 103 7 2554 2559 10.1182/blood-2003-06-1970 14670928
23. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. B Xia JC Dorsman N Ameziane Y de Vries MA Rooimans Q Sheng G Pals A Errami E Gluckman J Llera, Nat Genet 2007 39 2 159 161 10.1038/ng1942 17200672
24. Biallelic mutations in PALB2, which encodes a BRCA2 interacting protein, cause Fanconi anemia subtype FA-N and predispose to childhood cancer. S Reid D Schindler H Hanenberg K Barker S Hanks R Kalb K Neveling P Kelly S Seal M Freund, Nat Genet 2007 39 2 162 164 10.1038/ng1947 17200671
25. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. MS Sasaki A Tonomura, Cancer Research 1973 33 8 1829 1836 4352739
26. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. AD Auerbach, Experimental Hematology 1993 21 6 731 733 8500573
27. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. AR Meetei AL Medhurst C Ling Y Xue TR Singh P Bier J Steltenpool S Stone I Dokal CG Mathew, Nat Genet 2005 37 9 958 963 10.1038/ng1626 16116422
28. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. M Levitus MA Rooimans J Steltenpool NF Cool AB Oostra CG Mathew ME Hoatlin Q Waisfisz F Arwert JP De Winter, Blood 2004 103 7 2498 2503 10.1182/blood-2003- 08-2915 14630800
29. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. M Levitus Q Waisfisz BC Godthelp Y Vries S Hussain WW Wiegant E Elghalbzouri-Maghrani J Steltenpool MA Rooimans G Pals, Nat Genet 2005 37 9 934 935 10.1038/ng1625 16116423
30. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. O Levran C Attwooll RT Henry KL Milton K Neveling P Rio SD Batish R Kalb E Velleuer S Barral, Nat Genet 2005 37 9 931 933 10.1038/ng1624 16116424
31. Biallelic inactivation of BRCA2 in Fanconi anemia. NG Howlett T Taniguchi S Olson B Cox Q Waisfisz C De Die-Smulders N Persky M Grompe H Joenje G Pals, Science 2002 297 5581 606 609 10.1126/science.1073834 12065746
32. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. B Xia Q Sheng K Nakanishi A Ohashi J Wu N Christ X Liu M Jasin FJ Couch DM Livingston, Mol Cell 2006 22 6 719 729 10.1016/j.molcel.2006.05.022 16793542
33. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. R Litman M Peng Z Jin F Zhang J Zhang S Powell PR Andreassen SB Cantor, Cancer Cell 2005 8 3 255 265 10.1016/j.ccr.2005.08.004 16153896
34. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. I Garcia-Higuera T Taniguchi S Ganesan MS Meyn C Timmers J Hejna M Grompe AD D'Andrea, Mol Cell 2001 7 2 249 262 10.1016/S1097-2765(01)00173-3 11239454
35. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. X Wang PR Andreassen AD D'Andrea, Mol Cell Biol 2004 24 13 5850 5862 15199141 10.1128/MCB.24.13.5850-5862.2004
36. BRCA1-independent ubiquitination of FANCD2. CJ Vandenberg F Gergely CY Ong P Pace DL Mallery K Hiom KJ Patel, Mol Cell 2003 12 1 247 254 10.1016/S1097-2765(03)00281-8 12887909
37. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. AR Meetei S Sechi M Wallisch D Yang MK Young H Joenje ME Hoatlin W Wang, Mol Cell Biol 2003 23 10 3417 3426 12724401 10.1128/MCB.23.10.3417-3426. 2003
38. A novel ubiquitin ligase is deficient in Fanconi anemia. AR Meetei JP de Winter AL Medhurst M Wallisch Q Waisfisz HJ van de Vrugt AB Oostra Z Yan C Ling CE Bishop, Nat Genet 2003 35 2 165 170 10.1038/ng1241 12973351
39. Scores of RINGS but no PHDs in ubiquitin signaling. L Aravind LM Iyer EV Koonin, Cell Cycle 2003 2 2 123 126 12695663
40. No evidence for PHD fingers as ubiquitin ligases. H Scheel K Hofmann, Trends Cell Biol 2003 13 6 285 287 author reply 287-288 10.1016/S0962-8924(03) 00102-8 12791292
41. The PHD finger, a nuclear protein-interaction domain. M Bienz, Trends Biochem Sci 2006 31 1 35 40 10.1016/j.tibs.2005.11.001 16297627
42. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. YJ Machida Y Machida Y Chen AM Gurtan GM Kupfer AD D'Andrea A Dutta, Mol Cell 2006 23 4 589 596 10.1016/j.molcel.2006.06.024 16916645
43. Direct DNA binding activity of the Fanconi anemia D2 protein. WH Park S Margossian AA Horwitz AM Simons AD D'Andrea JD Parvin, J Biol Chem 2005 280 25 23593 23598 10.1074/jbc.M503730200 15849361
44. Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. R Montes de Oca PR Andreassen SP Margossian RC Gregory T Taniguchi X Wang S Houghtaling M Grompe AD D'Andrea, Blood 2005 105 3 1003 1009 10.1182/blood-2003-11-3997 15454491
45. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. T Taniguchi I Garcia-Higuera PR Andreassen RC Gregory M Grompe AD D'Andrea, Blood 2002 100 7 2414 2420 10.1182/blood-2002-01-0278 12239151
46. ATR couples FANCD2 monoubiquitination to the DNA-damage response. PR Andreassen AD D'Andrea T Taniguchi, Genes Dev 2004 18 16 1958 1963 15314022 10.1101/gad.1196104
47. A FancD2-monoubiquitin fusion reveals hidden functions of Fanconi anemia core complex in DNA repair. N Matsushita H Kitao M Ishiai N Nagashima S Hirano K Okawa T Ohta DS Yu PJ McHugh ID Hickson, Mol Cell 2005 19 6 841 847 10.1016/j.molcel.2005.08.018 16168378
48. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. SM Nijman TT Huang AM Dirac TR Brummelkamp RM Kerkhoven AD D'Andrea R Bernards, Mol Cell 2005 17 3 331 339 10.1016/j.molcel.2005.01.008 15694335
49. Regulation of monoubiquitinated PCNA by DUB autocleavage. TT Huang SM Nijman KD Mirchandani PJ Galardy MA Cohn W Haas SP Gygi HL Ploegh R Bernards AD D'Andrea, Nat Cell Biol 2006 8 4 339 347 10.1038/ncb1378 16531995
50. Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. PL Kannouche J Wing AR Lehmann, Mol Cell 2004 14 4 491 500 10.1016/S1097-2765(04) 00259-X 15149598
51. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. C Hoege B Pfander GL Moldovan G Pyrowolakis S Jentsch, Nature 2002 419 6903 135 141 10.1038/nature00991 12226657
52. Repair of DNA interstrand cross-links. ML Dronkert R Kanaar, Mutat Res 2001 486 4 217 247 11516927
53. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. W Niedzwiedz G Mosedale M Johnson CY Ong P Pace KJ Patel, Mol Cell 2004 15 4 607 620 10.1016/j.molcel.2004.08.009 15327776
54. Interaction of FANCD2 and NBS1 in the DNA damage response. K Nakanishi T Taniguchi V Ranganathan HV New LA Moreau M Stotsky CG Mathew MB Kastan DT Weaver AD D'Andrea, Nat Cell Biol 2002 4 12 913 920 10.1038/ncb879 12447395
55. FANCE: the link between Fanconi anaemia complex assembly and activity. P Pace M Johnson WM Tan G Mosedale C Sng M Hoatlin J de Winter H Joenje F Gergely KJ Patel, EMBO J 2002 21 13 3414 3423 12093742 10.1093/emboj/cdf355
56. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. S Hussain E Witt PA Huber AL Medhurst A Ashworth CG Mathew, Hum Mol Genet 2003 12 19 2503 2510 10.1093/hmg/ddg266 12915460
57. BRCA2 is required for homology-directed repair of chromosomal breaks. ME Moynahan AJ Pierce M Jasin, Mol Cell 2001 7 2 263 272 10.1016/S1097-2765(01) 00174-5 11239455
58. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. AA Davies JY Masson MJ McIlwraith AZ Stasiak A Stasiak AR Venkitaraman SC West, Mol Cell 2001 7 2 273 282 10.1016/S1097-2765(01)00175-7 11239456
59. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. M Digweed S Rothe I Demuth R Scholz D Schindler M Stumm M Grompe A Jordan K Sperling, Carcinogenesis 2002 23 7 1121 1126 10.1093/carcin/23.7.1121 12117768
60. DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. P Pichierri D Averbeck F Rosselli, Hum Mol Genet 2002 11 21 2531 2546 10.1093/hmg/11.21.2531 12354779
61. Genetic steps of mammalian homologous repair with distinct mutagenic consequences. JM Stark AJ Pierce J Oh A Pastink M Jasin, Mol Cell Biol 2004 24 21 9305 9316 15485900 10.1128/MCB.24.21.9305-9316.2004
62. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. K Nakanishi YG Yang AJ Pierce T Taniguchi M Digweed AD D'Andrea ZQ Wang M Jasin, Proc Natl Acad Sci U S A 2005 102 4 1110 1115 15650050 10.1073/pnas.0407796102
63. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. BC Godthelp WW Wiegant Q Waisfisz AL Medhurst F Arwert H Joenje MZ Zdzienicka, Mutat Res 2006 594 1-2 39 48 16154163
64. The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells. YG Yang Z Herceg K Nakanishi I Demuth C Piccoli J Michelon G Hildebrand M Jasin M Digweed ZQ Wang, Carcinogenesis 2005 26 10 1731 1740 10.1093/carcin/bgi134 15905196
65. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. S Hirano K Yamamoto M Ishiai M Yamazoe M Seki N Matsushita M Ohzeki YM Yamashita H Arakawa JM Buerstedde, Embo J 2005 24 2 418 427 15616572 10.1038/sj.emboj.7600534
66. Fanconi anemia protein FANCD2 promotes immunoglobulin gene conversion and DNA repair through a mechanism related to homologous recombination. K Yamamoto S Hirano M Ishiai K Morishima H Kitao K Namikoshi M Kimura N Matsushita H Arakawa JM Buerstedde, Mol Cell Biol 2005 25 1 34 43 15601828 10.1128/MCB.25.1.34-43.2005
67. Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. K Yamamoto M Ishiai N Matsushita H Arakawa JE Lamerdin JM Buerstedde M Tanimoto M Harada LH Thompson M Takata, Mol Cell Biol 2003 23 15 5421 5430 12861027 10.1128/MCB.23.15.5421-5430.2003
68. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. WL Bridge CJ Vandenberg RJ Franklin K Hiom, Nat Genet 2005 37 9 953 957 10.1038/ng1627 16116421
69. Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage. A Ohashi MZ Zdzienicka J Chen FJ Couch, J Biol Chem 2005 280 15 14877 14883 10.1074/jbc.M414669200 15671039
70. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. G Mosedale W Niedzwiedz A Alpi F Perrina JB Pereira-Leal M Johnson F Langevin P Pace KJ Patel, Nat Struct Mol Biol 2005 12 9 763 771 10.1038/nsmb981 16116434
71. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function. SB Cantor DW Bell S Ganesan EM Kass R Drapkin S Grossman DC Wahrer DC Sgroi WS Lane DA Haber, Cell 2001 105 1 149 160 10.1016/S0092-8674(01)00304-X 11301010
72. BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting. IA Manke DM Lowery A Nguyen MB Yaffe, Science 2003 302 5645 636 639 10.1126/science.1088877 14576432
73. The BRCT domain is a phospho-protein binding domain. X Yu CC Chini M He G Mer J Chen, Science 2003 302 5645 639 642 10.1126/science.1088753 14576433
74. Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. T Taniguchi I Garcia-Higuera B Xu PR Andreassen RC Gregory ST Kim WS Lane MB Kastan AD D'Andrea, Cell 2002 109 4 459 472 10.1016/S0092-8674(02)00747- X 12086603
75. Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice. SR Fagerlie T Koretsky B Torok-Storb GC Bagby, J Immunol 2004 173 6 3863 3870 15356134
76. The Fanconi anemia proteins functionally interact with the protein kinase regulated by RNA (PKR). X Zhang J Li DP Sejas KR Rathbun GC Bagby Q Pang, J Biol Chem 2004 279 42 43910 43919 10.1074/jbc.M403884200 15299030
77. Oxidant hypersensitivity of Fanconi anemia type C-deficient cells is dependent on a redox-regulated apoptotic pathway. MR Saadatzadeh K Bijangi-Vishehsaraei P Hong H Bergmann LS Haneline, J Biol Chem 2004 279 16 16805 16812 10.1074/jbc.M313721200 14764578
78. The anti-apoptotic function of Hsp70 in the PKR-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. Q Pang TA Christianson W Keeble T Koretsky GC Bagby, J Biol Chem 2002 277 51 49638 49643 10.1074/jbc.M209386200 12397061
79. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors. Q Pang S Fagerlie TA Christianson W Keeble G Faulkner J Diaz RK Rathbun GC Bagby, Mol Cell Biol 2000 20 13 4724 4735 10848598 10.1128/MCB.20.13.4724-4735.2000
80. Regulation of the Fanconi anemia group C protein through proteolytic modification. I Brodeur I Goulet CS Tremblay C Charbonneau MC Delisle C Godin C Huard EW Khandjian M Buchwald G Levesque, J Biol Chem 2004 279 6 4713 4720 10.1074/jbc.M301291200 14625294
81. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. T Taniguchi M Tischkowitz N Ameziane SV Hodgson CG Mathew H Joenje SC Mok AD D'Andrea, Nat Med 2003 9 5 568 574 10.1038/nm852 12692539
82. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway. Z Wang M Li S Lu Y Zhang H Wang, Cancer Biol Ther 2006 5 3 256 260 10.1158/1535-7163.MCT-05-0299 16418574
83. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin. VS Dhillon M Shahid SA Husain, Mol Cancer 2004 3 33 15574200 10.1186/1476-4598-3-33
84. FANCF methylation contributes to chemoselectivity in ovarian cancer. OI Olopade M Wei, Cancer Cell 2003 3 5 417 420 10.1016/S1535-6108(03)00111-9 12781358
85. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. CJ Marsit M Liu HH Nelson M Posner M Suzuki KT Kelsey, Oncogene 2004 23 4 1000 1004 10.1038/sj.onc.1207256 14647419
86. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. G Narayan H Arias-Pulido SV Nandula K Basso DD Sugirtharaj H Vargas M Mansukhani J Villella L Meyer A Schneider, Cancer Res 2004 64 9 2994 2997 10.1158/0008-5472.CAN-04-0245 15126331
87. Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors. S Koul JM McKiernan G Narayan J Houldsworth J Bacik DL Dobrzynski AM Assaad M Mansukhani VE Reuter GJ Bosl, Mol Cancer 2004 3 16 15149548 10.1186/1476-4598-3-16
88. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia. M Tischkowitz N Ameziane Q Waisfisz JP De Winter R Harris T Taniguchi A D'Andrea SV Hodgson CG Mathew H Joenje, Br J Haematol 2003 123 3 469 471 10.1046/j.1365-2141.2003.04640.x 14617007
89. Fanconi anemia gene mutations in young-onset pancreatic cancer. MS van Der Heijden CJ Yeo RH Hruban SE Kern, Cancer Res 2003 63 10 2585 2588 12750283
90. Functional screen of the Fanconi anemia pathway in cancer cells by fancd2 immunoblot. MS van Der Heijden JR Brody SE Kern, Cancer Biol Ther 2004 3 6 534 537 15107617
91. Functional defects in the Fanconi anemia pathway in pancreatic cancer cells. MS van der Heijden JR Brody E Gallmeier SC Cunningham DA Dezentje D Shen RH Hruban SE Kern, Am J Pathol 2004 165 2 651 657 15277238
92. Analysis of the Fanconi anaemia complementation group A gene in acute myeloid leukaemia. A Condie RL Powles CD Hudson V Shepherd S Bevan MR Yuille RS Houlston, Leuk Lymphoma 2002 43 9 1849 1853 10.1080/1042819021000009274 12685843
93. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. MD Tischkowitz NV Morgan D Grimwade C Eddy S Ball I Vorechovsky S Langabeer R Stoger SV Hodgson CG Mathew, Leukemia 2004 18 3 420 425 10.1038/sj.leu.2403280 14749703
94. Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia. MW Lensch M Tischkowitz TA Christianson CA Reifsteck SA Speckhart PM Jakobs ME O'Dwyer SB Olson MM Le Beau SV Hodgson, Blood 2003 102 1 7 16 10.1182/blood-2002-09-2781 12637330
95. Hallmarks of 'BRCAness' in sporadic cancers. N Turner A Tutt A Ashworth, Nat Rev Cancer 2004 4 10 814 819 10.1038/nrc1457 15510162
96. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. FJ Couch MR Johnson K Rabe L Boardman R McWilliams M de Andrade G Petersen, Cancer Res 2005 65 2 383 386 15695377
97. Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. S Seal D Thompson A Renwick A Elliott P Kelly R Barfoot T Chagtai H Jayatilake M Ahmed K Spanova, Nat Genet 2006 38 11 1239 1241 10.1038/ng1902 17033622
98. The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells. Q Chen PC Van der Sluis D Boulware LA Hazlehurst WS Dalton, Blood 2005 106 2 698 705 15802532 10.1182/blood-2004-11-4286
99. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor. MS van der Heijden JR Brody DA Dezentje E Gallmeier SC Cunningham MJ Swartz AM DeMarzo GJ Offerhaus WH Isacoff RH Hruban, Clin Cancer Res 2005 11 20 7508 7515 10.1158/1078-0432.CCR-05-1048 16243825
100. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA. M Ferrer JP de Winter DC Mastenbroek DT Curiel WR Gerritsen G Giaccone FA Kruyt, Cancer Gene Ther 2004 11 8 539 546 10.1038/sj.cgt.7700734 15192709
101. Mice with a targeted disruption of the Fanconi anemia homolog fanca. NC Cheng HJ van De Vrugt MA van Der Valk AB Oostra P Krimpenfort Y de Vries H Joenje A Berns F Arwert, Hum Mol Genet 2000 9 12 1805 1811 10.1093/hmg/9.12.1805 10915769
102. Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. JC Wong N Alon C McKerlie JR Huang MS Meyn M Buchwald, Hum Mol Genet 2003 12 16 2063 2076 10.1093/hmg/ddg219 12913077
103. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. M Chen DJ Tomkins W Auerbach C McKerlie H Youssoufian L Liu O Gan M Carreau A Auerbach T Groves, Nature Genetics 1996 12 4 448 451 10.1038/ng0496-448 8630504
104. Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. MA Whitney G Royle MJ Low MA Kelly MK Axthelm C Reifsteck S Olson RE Braun MC Heinrich RK Rathbun, Blood 1996 88 1 49 58 8704201
105. Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. M Koomen NC Cheng HJ van de Vrugt BC Godthelp MA van der Valk AB Oostra MZ Zdzienicka H Joenje F Arwert, Hum Mol Genet 2002 11 3 273 281 10.1093/hmg/11.3.273 11823446
106. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Y Yang Y Kuang RM De Oca T Hays L Moreau N Lu B Seed AD D'Andrea, Blood 2001 98 12 3435 3440 10.1182/blood.V98.12.3435 11719385
107. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. S Houghtaling C Timmers M Noll MJ Finegold SN Jones MS Meyn M Grompe, Genes Dev 2003 17 16 2021 2035 12893777 10.1101/gad.1103403
108. Fanconi anemia group A and C double-mutant mice. Functional evidence for a multi-protein Fanconi anemia complex. M Noll KP Battaile R Bateman TP Lax K Rathbun C Reifsteck G Bagby M Finegold S Olson M Grompe, Exp Hematol 2002 30 7 679 688 10.1016/S0301-472X(02)00838-X 12135664
109. A novel gene, Pog, is necessary for primordial germ cell proliferation in the mouse and underlies the germ cell deficient mutation, gcd. AI Agoulnik B Lu Q Zhu C Truong MT Ty N Arango KK Chada CE Bishop, Hum Mol Genet 2002 11 24 3047 3053 10.1093/hmg/11.24.3047 12417526
110. Hematopoietic dysfunction in a mouse model for Fanconi anemia group D1. S Navarro NW Meza O Quintana-Bustamante JA Casado A Jacome K McAllister S Puerto J Surralles JC Segovia JA Bueren, Mol Ther 2006 14 4 525 535 10.1016/j.ymthe.2006.05.018 16859999
111. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage. M Carreau OI Gan L Liu M Doedens C McKerlie JE Dick M Buchwald, Blood 1998 91 8 2737 2744 9531583
112. Not-so-novel phenotypes in the Fanconi anemia group D2 mouse model. M Carreau, Blood 2004 103 6 2430 10.1182/blood-2003-11-3946 14998919
113. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. ME Moynahan, Oncogene 2002 21 58 8994 9007 10.1038/sj.onc.1206177 12483515
114. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice. P Rio JC Segovia H Hanenberg JA Casado J Martinez K Gottsche NC Cheng HJ Van De Vrugt F Arwert H Joenje, Blood 2002 100 6 2032 2039 12200363
115. Phenotypic correction of Fanconi anemia group C knockout mice. KA Gush KL Fu M Grompe CE Walsh, Blood 2000 95 2 700 704 10627482
116. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C. M Noll RL Bateman AD D'Andrea M Grompe, Mol Ther 2001 3 1 14 23 10.1006/mthe.2000.0226 11162306
117. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors. F Galimi M Noll Y Kanazawa T Lax C Chen M Grompe IM Verma, Blood 2002 100 8 2732 2736 10.1182/blood-2002-04-1245 12351379
118. Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution. LS Haneline X Li SL Ciccone P Hong Y Yang HE Broxmeyer SH Lee A Orazi EF Srour DW Clapp, Blood 2003 101 4 1299 1307 10.1182/blood-2002-08- 2404 12393504
119. Functional correction of Fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector. K Yamada JC Olsen M Patel KW Rao CE Walsh, Mol Ther 2001 3 4 485 490 10.1006/mthe.2001.0287 11319908
120. Phenotype correction of Fanconi anemia group a hematopoietic stem cells using lentiviral vector. K Yamada A Ramezani RG Hawley W Ebell F Arwert LW Arnold CE Walsh, Mol Ther 2003 8 4 600 610 10.1016/S1525-0016(03)00223-5 14529833
121. Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy. X Li MM Le Beau S Ciccone FC Yang B Freie S Chen J Yuan P Hong A Orazi LS Haneline, Blood 2005 105 9 3465 3471 15644418 10.1182/blood-2004-06-2483
122. Short-term granulocyte colony-stimulating factor and erythropoietin treatment enhances hematopoiesis and survival in the mitomycin C-conditioned Fancc(-/-) mouse model, while long-term treatment is ineffective. M Carreau L Liu OI Gan JK Hitzler JE Dick M Buchwald, Blood 2002 100 4 1499 1501 10.1182/blood-2001-11-0007 12149239
123. The Fanconi anemia gene network is conserved from zebrafish to human. TA Titus DR Selvig B Qin C Wilson AM Starks BA Roe JH Postlethwait, Gene 2006 371 2 211 223 10.1016/j.gene.2005.11.038 16515849
124. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. A Sobeck S Stone V Costanzo B de Graaf T Reuter J de Winter M Wallisch Y Akkari S Olson W Wang, Mol Cell Biol 2006 26 2 425 437 16382135 10.1128/MCB.26.2.425-437.2006
125. Drosophila homologs of FANCD2 and FANCL function in DNA repair. LR Marek AE Bale, DNA Repair (Amst) 2006 5 11 1317 1326 10.1016/j.dnarep.2006.05.044 16860002
126. C. elegans FANCD2 responds to replication stress and functions in interstrand cross-link repair. SJ Collis LJ Barber JD Ward JS Martin SJ Boulton, DNA Repair (Amst) 2006 5 11 1398 1406 10.1016/j.dnarep.2006.06.010 16914393
127. Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis. TX Liu NG Howlett M Deng DM Langenau K Hsu J Rhodes JP Kanki AD D'Andrea AT Look, Dev Cell 2003 5 6 903 914 10.1016/S1534-5807(03) 00339-3 14667412
128. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. D Chirnomas T Taniguchi M de la Vega AP Vaidya M Vasserman AR Hartman R Kennedy R Foster J Mahoney MV Seiden, Mol Cancer Ther 2006 5 4 952 961 10.1158/1535-7163.MCT-05-0493 16648566
129. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. AL Cheng CH Hsu JK Lin MM Hsu YF Ho TS Shen JY Ko JT Lin BR Lin W Ming-Shiang, Anticancer Res 2001 21 4B 2895 2900 11712783
130. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. H Yang PD Jeffrey J Miller E Kinnucan Y Sun NH Thoma N Zheng PL Chen WH Lee NP Pavletich, Science 2002 297 5588 1837 1848 10.1126/science.297.5588. 1837 12228710
131. Structural determinants of human fancf protein that function in the assembly of a DNA damage signaling complex. P Kowal AM Gurtan P Stuckert AD D'Andrea T Ellenberger, J Biol Chem 2006 on line publication 17082180
132. The DNA repair helicases XPD and FancJ have essential iron-sulfur domains. J Rudolf V Makrantoni WJ Ingledew MJ Stark MF White, Mol Cell 2006 23 6 801 808 10.1016/j.molcel.2006.07.019 16973432
133. Positional cloning of a novel Fanconi anemia gene, FANCD2. C Timmers T Taniguchi J Hejna C Reifsteck L Lucas D Bruun M Thayer B Cox S Olson AD D'Andrea, Mol Cell 2001 7 2 241 248 10.1016/S1097-2765(01)00172-1 11239453
134. FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. AR Meetei Z Yan W Wang, Cell Cycle 2004 3 2 179 181 14712086
135. RAD-51-dependent and -independent roles of a Caenorhabditis elegans BRCA2-related protein during DNA double-strand break repair. JS Martin N Winkelmann MI Petalcorin MJ McIlwraith SJ Boulton, Mol Cell Biol 2005 25 8 3127 3139 15798199 10.1128/MCB.25.8.3127-3139.2005
136. The Fanconi anemia gene product FANCF is a flexible adaptor protein. F Leveille E Blom AL Medhurst P Bier H Laghmani el M Johnson MA Rooimans A Sobeck Q Waisfisz F Arwert, J Biol Chem 2004 279 38 39421 39430 10.1074/jbc.M407034200 15262960
137. Identification of FAAP24, a Fanconi Anemia Core Complex Protein that Interacts with FANCM. A Ciccia C Ling R Coulthard Z Yan Y Xue AR Meetei H Laghmani el H Joenje N McDonald JP de Winter, Mol Cell 2007 25 3 331 343 10.1016/j.molcel.2007.01.003 17289582